Strongyloides ratti: In Vitro and In Vivo Activity of Tribendimidine
2008

Effect of Tribendimidine on Strongyloides ratti

Sample size: 48 publication 10 minutes Evidence: high

Author Information

Author(s): Jennifer Keiser, Kai Thiemann, Yvette Endriss, Jürg Utzinger

Primary Institution: Swiss Tropical Institute, Basel, Switzerland

Hypothesis

Does tribendimidine exhibit activity against Strongyloides ratti in vitro and in vivo?

Conclusion

Tribendimidine shows significant activity against Strongyloides ratti in both laboratory and animal studies.

Supporting Evidence

  • Tribendimidine killed S. ratti larvae in vitro within 24 hours at certain concentrations.
  • A single dose of 50 mg/kg tribendimidine eliminated adult S. ratti in infected rats.
  • Tribendimidine was less effective against younger stages of S. ratti.

Takeaway

Tribendimidine can kill a type of worm that causes disease in humans, and it works better than some other medicines.

Methodology

The study involved in vitro tests on larvae and in vivo tests on infected rats to assess the effectiveness of tribendimidine.

Limitations

The study primarily used animal models, and results may not directly translate to humans.

Participant Demographics

Male Wistar rats, age: 3 weeks, weight: ∼80 g.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000136

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication